MIST - Milestone Pharmaceuticals Inc
IEX Last Trade
1.425
0.005 0.351%
Share volume: 39,716
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.42
0.01
0.35%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
Report Date | 2022-05-12 | 2022-08-10 | 2022-11-10 | 2023-03-29 | 2023-05-11 | 2023-08-10 | 2023-11-13 | 2024-03-21 | |
Total revenue | 0.000 | 0.000 | 1.500 M | 3.500 M | 1.000 M | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 1.500 M | 3.500 M | 1.000 M | 0.000 | 0.000 | 0.000 | |
nan% | inf% | 133.33% | -71.43% | -100.00% | nan% | nan% | |||
Operating expenses | 12.411 M | 14.575 M | 13.860 M | 14.701 M | 14.146 M | 13.067 M | 10.948 M | 8.823 M | |
Selling general and admin | 3.643 M | 3.918 M | 4.034 M | 4.123 M | 3.889 M | 4.445 M | 4.227 M | 3.371 M | |
Research and development | 8.768 M | 10.657 M | 9.826 M | 10.578 M | 10.257 M | 8.622 M | 6.721 M | 5.452 M | |
Total expenses | 14.047 M | 16.806 M | 16.530 M | 17.259 M | 16.502 M | 16.436 M | 15.360 M | 13.800 M | |
19.64% | -1.64% | 4.41% | -4.39% | -0.40% | -6.55% | -10.16% | |||
Operating income | -14.047 M | -16.806 M | -15.030 M | -13.759 M | -15.502 M | -16.436 M | -15.360 M | -13.800 M | |
Ebit | -14.047 M | -16.806 M | -15.030 M | -13.759 M | -15.502 M | -16.436 M | -15.360 M | -13.800 M | |
Pretax income | -14.007 M | -16.648 M | -14.556 M | -13.177 M | -14.950 M | -16.043 M | -15.081 M | -13.611 M | |
18.85% | -12.57% | -9.47% | 13.46% | 7.31% | -6.00% | -9.75% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -14.007 M | -16.648 M | -14.556 M | -13.177 M | -14.950 M | -16.043 M | -15.081 M | -13.611 M | |
-18.85% | 12.57% | 9.47% | -13.46% | -7.31% | 6.00% | 9.75% | |||
Net income | -14.007 M | -16.648 M | -14.556 M | -13.177 M | -14.950 M | -16.043 M | -15.081 M | -13.611 M | |
-18.85% | 12.57% | 9.47% | -13.46% | -7.31% | 6.00% | 9.75% |